A study shows large language models can predict immunotherapy responses in liver cancer as accurately as experienced doctors.
Key Details
- 1Research led by Prof. Hai Li at Hefei Institutes systematically assessed LLMs' ability to predict liver cancer treatment response.
- 2LLMs tested: GPT-4, GPT-4o, Google Gemini, DeepSeek, and a hybrid Gemini-GPT model.
- 3Dataset included clinical and imaging data from 186 unresectable HCC patients.
- 4Gemini-GPT matched senior (15+ years) doctor accuracy and surpassed less-experienced clinicians in both speed and accuracy.
- 5Hybrid and logical strategies improved LLM performance and consistency, especially in identifying likely responders to therapy.
- 6Published in the Journal of Medical Systems on May 15, 2025.
Why It Matters
This work demonstrates the emerging capability of LLMs to support and enhance personalized cancer treatment decisions, showing they can complement or even match the expertise of experienced radiologists and oncologists in outcome prediction.
Source
EurekAlert
Related News
•EurekAlert
AI Enables Rapid Body Composition Analysis on Routine MRI to Predict Cardiometabolic Risk
An open-source AI tool can quickly and accurately assess body composition from routine MRI, helping identify patients at elevated cardiometabolic risk.
•EurekAlert
Study Finds Gaps in FDA Safety Reporting for AI Medical Devices
A study highlights insufficient standardized safety and efficacy assessments for FDA-cleared AI/ML medical devices.
•EurekAlert
MIT Introduces Interactive AI System for Fast Medical Image Annotation
MIT researchers have developed MultiverSeg, an interactive AI tool enabling efficient, user-driven segmentation of biomedical image datasets without prior model training.